Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) Return on Equity (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Return on Equity for 5 consecutive years, with 0.72% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 6.0% to 0.72% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.72% through Dec 2025, down 6.0% year-over-year, with the annual reading at 0.58% for FY2025, 3.0% down from the prior year.
  • Return on Equity hit 0.72% in Q4 2025 for Kezar Life Sciences, down from 0.7% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.22% in Q3 2022 to a low of 0.73% in Q2 2025.
  • Historically, Return on Equity has averaged 0.48% across 5 years, with a median of 0.5% in 2023.
  • Biggest five-year swings in Return on Equity: increased 10bps in 2022 and later decreased -28bps in 2024.
  • Year by year, Return on Equity stood at 0.35% in 2021, then increased by 29bps to 0.25% in 2022, then plummeted by -105bps to 0.5% in 2023, then crashed by -32bps to 0.67% in 2024, then dropped by -8bps to 0.72% in 2025.
  • Business Quant data shows Return on Equity for KZR at 0.72% in Q4 2025, 0.7% in Q3 2025, and 0.73% in Q2 2025.